We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.08B
AUM Growth
-$109M
Cap. Flow
-$88M
Cap. Flow %
-4.22%
Top 10 Hldgs %
17.5%
Holding
3,019
New
52
Increased
262
Reduced
623
Closed
69

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$2.94M
2
VZ icon
Verizon
VZ
+$2.82M
3
EHC icon
Encompass Health
EHC
+$2.04M
4
WBS icon
Webster Financial
WBS
+$1.98M
5
ABBV icon
AbbVie
ABBV
+$1.93M

Top Sells

Rank Stock Value
1
AMLP icon
Alerian MLP ETF
AMLP
+$16.3M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.26M
3
IJK icon
iShares S&P Mid-Cap 400 Growth ETF
IJK
+$3.76M
4
SIVB
SVB Financial Group
SIVB
+$3.69M
5
AAPL icon
Apple
AAPL
+$3.61M

Sector Composition

Rank Sector Weight
1 Technology 13.98%
2 Financials 13.14%
3 Industrials 10.38%
4 Healthcare 8.96%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FMB icon
2001
First Trust Managed Municipal ETF
FMB
$2.07B
$41K ﹤0.01%
796
+85
+12% +$4.49K
HYT icon
2002
BlackRock Corporate High Yield Fund
HYT
$1.37B
$41K ﹤0.01%
+3,900
New +$41.9K
JBSS icon
2003
John B. Sanfilippo & Son
JBSS
$1.01B
$41K ﹤0.01%
716
– –
MBWM icon
2004
Mercantile Bank Corp
MBWM
$1.06B
$41K ﹤0.01%
1,239
– –
MCFT icon
2005
MasterCraft Boat Holdings
MCFT
$598M
$41K ﹤0.01%
1,615
– –
MDGL icon
2006
Madrigal Pharmaceuticals
MDGL
$11.7B
$41K ﹤0.01%
355
– –
OMER icon
2007
Omeros
OMER
$1.26B
$41K ﹤0.01%
3,655
– –
SAH icon
2008
Sonic Automotive
SAH
$2.51B
$41K ﹤0.01%
2,180
– –
TCRT icon
2009
Alaunos Therapeutics
TCRT
$4.86M
$41K ﹤0.01%
70
– –
UIS icon
2010
Unisys
UIS
$210M
$41K ﹤0.01%
3,852
– –
ZUMZ icon
2011
Zumiez
ZUMZ
$319M
$41K ﹤0.01%
1,698
– –
OMN
2012
DELISTED
OMNOVA Solutions Inc.
OMN
$41K ﹤0.01%
3,910
– –
HSKA
2013
DELISTED
Heska Corp
HSKA
$41K ﹤0.01%
514
– –
BCRX icon
2014
BioCryst Pharmaceuticals
BCRX
$2.51B
$40K ﹤0.01%
8,297
+1,600
+24% +$8.22K
CTRN icon
2015
Citi Trends
CTRN
$621M
$40K ﹤0.01%
1,298
– –
FATE icon
2016
Fate Therapeutics
FATE
$294M
$40K ﹤0.01%
4,100
+754
+23% +$7.22K
GRC icon
2017
Gorman-Rupp
GRC
$2.11B
$40K ﹤0.01%
1,373
– –
HZO icon
2018
MarineMax
HZO
$1.15B
$40K ﹤0.01%
2,047
– –
KPTI icon
2019
Karyopharm Therapeutics
KPTI
$45.1M
$40K ﹤0.01%
198
– –
MYE icon
2020
Myers Industries
MYE
$1.25B
$40K ﹤0.01%
1,882
– –
QCRH icon
2021
QCR Holdings
QCRH
$1.75B
$40K ﹤0.01%
901
– –
SCZ icon
2022
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$40K ﹤0.01%
618
-71
-10% -$4.68K
WSBF icon
2023
Waterstone Financial
WSBF
$385M
$40K ﹤0.01%
2,330
– –
PENG
2024
Penguin Solutions Inc
PENG
$3.12B
$40K ﹤0.01%
1,608
+576
+56% +$10.9K
VRTV
2025
DELISTED
VERITIV CORPORATION
VRTV
$40K ﹤0.01%
1,008
– –
79 80
81
82 83

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Ameritas Investment Partners held 3,019 positions worth $2.08B, down 5% from $2.19B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Ameritas Investment Partners withdrew a net $88M in Q1 2018, closing 69 positions and reducing 623 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Encompass Health worth $2.16M.

  • Ameritas Investment Partners's largest Q1 2018 buy was Encompass Health: 47,494 shares worth $2.16M.
  • Ameritas Investment Partners added most to Visa in Q1 2018, an estimated $2.94M increase.
  • Ameritas Investment Partners's biggest Q1 2018 reduction was Alerian MLP ETF, cutting an estimated $16.3M.
  • Ameritas Investment Partners fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $1.75M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $2.08B portfolio in Q1 2018.
  • Ameritas Investment Partners opened 52 new positions and closed 69 in Q1 2018.
  • Ameritas Investment Partners's portfolio value fell 5% quarter-over-quarter to $2.08B.

Based on Ameritas Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.